glp-1 drugs in development Agonists Weight Loss Market Report, 2025-2030 GLP Agonist Clinical Trial Pipeline
Description
D.HahnE
Factors Affecting Adherence Injection Aversion: Many adolescents struggle with weekly or daily injections, leading to treatment discontinuation
Landmark analysis: a primer
2015;308:E6419
Glucagon-like peptide-1 inhibits prandial gastrointestinal motility through myenteric neuronal mechanisms in humans
C., Fukuda, L
